星球细胞衍生型的斯坦尼奥卡尔-1通过NF-κB依赖的神经炎症调节发
Xinyue Guan1, Wenzeng Wang1, Qiannan Song2
1Department of Clinical Specialty of Pediatrics of Traditional Chinese Medicine, Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Cell cycle (Georgetown, Tex.)
|September 29, 2025
概括
来自天体细胞的STC1通过激活NF-κB通路,增加神经炎症和神经元损伤,加剧叶 (TLE). STC1敲击提供了一个潜在的治疗点为TLE.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 叶 (TLE) 是一种慢性神经系统疾病,其特征是经常性发作.
- 天体细胞衍生因子在TLE病原体中的作用仍然不完全理解.
- 研究TLE中Stanniocalcin-1 (STC1) 的表达和功能对于了解疾病机制至关重要.
研究的目的:
- 调查TLE中天体细胞衍生STC1的表达模式.
- 阐明STC1通过NF-κB信号通路调节神经炎症和的分子机制.
主要方法:
- 使用开氨酸 (KA) 注射建立一个TLE小鼠模型.
- 在海马组织中评估STC1的表达和定位.
- 使用腺相关病毒 (AAV) 载体用于STC1基因过度表达和shRNA淘汰.
- 评估神经炎症,神经元存活率和活动.
- 使用qRT-PCR和免疫光学分析炎症性细胞因子水平和NF-κB通路激活.
主要成果:
- 在TLE小鼠的海马体中,STC1表达显著上调,主要是在反应性星球细胞 (GFAP阳性) 中.
- STC1过度表达加剧了KA诱导的神经炎症,微质激活和神经元损失.
- STC1敲击减弱了神经炎症反应和受保护的神经元.
- 通过促进p65酸化和核转移,STC1过度表达激活了NF-κB信号通路.
结论:
- 来自天体细胞的STC1在促进TLE相关的神经炎症和神经元损伤方面发挥着关键作用.
- 通过STC1介导的NF-κB信号通路的激活是导致发症的一个关键机制.
- 准星细胞-STC1-NF-κB轴代表了TLE的潜在治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827


